(Q43920062)

English

Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions

scientific article published on 10 April 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions (English)

1 reference

Europe PubMed Central

28 November 2017

chemoradiotherapy

0 references

Adaptive radiation therapy

0 references

1 reference

based on heuristic

inferred from title

9

object named as

Ling-Long Tang

1 reference

Europe PubMed Central

28 November 2017

author name string

Yong Chen

1

1 reference

Europe PubMed Central

28 November 2017

Ying Sun

2

1 reference

Europe PubMed Central

28 November 2017

Shao-Bo Liang

3

1 reference

Europe PubMed Central

28 November 2017

Jing-Feng Zong

4

1 reference

Europe PubMed Central

28 November 2017

Wen-Fei Li

5

1 reference

Europe PubMed Central

28 November 2017

Mo Chen

6

1 reference

Europe PubMed Central

28 November 2017

Lei Chen

7

1 reference

Europe PubMed Central

28 November 2017

Yan-Ping Mao

8

1 reference

Europe PubMed Central

28 November 2017

Ying Guo

10

1 reference

Europe PubMed Central

28 November 2017

Ai-Hua Lin

11

1 reference

Europe PubMed Central

28 November 2017

Meng-Zhong Liu

12

1 reference

Europe PubMed Central

28 November 2017

Jun Ma

13

1 reference

Europe PubMed Central

28 November 2017

language of work or name

0 references

publication date

10 April 2013

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

119

1 reference

Europe PubMed Central

28 November 2017

12

1 reference

Europe PubMed Central

28 November 2017

2230-2238

1 reference

Europe PubMed Central

28 November 2017

randomized experiment

0 references

Is the 1997 AJCC staging system for nasopharyngeal carcinoma prognostically useful for Chinese patient populations?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28049

21 January 2018

Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28049

21 January 2018

The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28049

21 January 2018

Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic varie

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28049

21 January 2018

Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28049

21 January 2018

Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28049

21 January 2018

Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28049

21 January 2018

Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28049

21 January 2018

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28049

21 January 2018

Concomitant chemoirradiation for stage III-IV nasopharyngeal carcinoma in Chinese patients: results of a matched cohort analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28049

21 January 2018

How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28049

21 January 2018

Cisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28049

21 January 2018

Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28049

21 January 2018

Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28049

21 January 2018

Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28049

21 January 2018

Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma: preliminary results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28049

21 January 2018

Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28049

21 January 2018

Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28049

21 January 2018

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28049

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28049

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28049

7 January 2021

based on heuristic

inferred from DOI database lookup

Overall Survival After Concurrent Cisplatin-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28049

7 January 2021

based on heuristic

inferred from DOI database lookup

The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28049

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.28049

1 reference

Europe PubMed Central

28 November 2017

release_dkqswz5wqfbgvpmtx2uhjm6jcy

1 reference

https://api.fatcat.wiki/v0/release/dkqswz5wqfbgvpmtx2uhjm6jcy

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

28 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43920062&oldid=2104396778"